O Brien Greene & Co. Inc Sells 1,343 Shares of Axon Enterprise, Inc. (NASDAQ:AXON)

O Brien Greene & Co. Inc trimmed its position in Axon Enterprise, Inc. (NASDAQ:AXON) by 37.5% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 2,242 shares of the biotechnology company’s stock after selling 1,343 shares during the quarter. O Brien Greene & Co. Inc’s holdings in Axon Enterprise were worth $1,332,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds have also recently added to or reduced their stakes in AXON. Concurrent Investment Advisors LLC lifted its stake in shares of Axon Enterprise by 12.1% in the 4th quarter. Concurrent Investment Advisors LLC now owns 877 shares of the biotechnology company’s stock valued at $521,000 after purchasing an additional 95 shares during the period. Hardy Reed LLC bought a new stake in Axon Enterprise in the fourth quarter valued at approximately $220,000. Ieq Capital LLC boosted its position in shares of Axon Enterprise by 10.5% during the fourth quarter. Ieq Capital LLC now owns 3,149 shares of the biotechnology company’s stock worth $1,872,000 after purchasing an additional 298 shares in the last quarter. ICICI Prudential Asset Management Co Ltd acquired a new position in shares of Axon Enterprise in the 4th quarter valued at $590,000. Finally, Financial Management Network Inc. raised its stake in Axon Enterprise by 10.0% during the 4th quarter. Financial Management Network Inc. now owns 550 shares of the biotechnology company’s stock worth $331,000 after buying an additional 50 shares during the period. 79.08% of the stock is owned by institutional investors.

Wall Street Analysts Forecast Growth

Several brokerages have issued reports on AXON. The Goldman Sachs Group raised their price target on Axon Enterprise from $500.00 to $700.00 and gave the stock a “buy” rating in a research report on Monday, January 27th. Needham & Company LLC boosted their price objective on shares of Axon Enterprise from $525.00 to $600.00 and gave the company a “buy” rating in a research report on Friday, November 8th. Morgan Stanley upgraded Axon Enterprise from an “equal weight” rating to an “overweight” rating and increased their target price for the stock from $500.00 to $700.00 in a report on Tuesday, December 3rd. Northland Securities raised their price target on shares of Axon Enterprise from $365.00 to $550.00 and gave the stock an “outperform” rating in a research note on Monday, November 11th. Finally, TD Cowen started coverage on shares of Axon Enterprise in a research report on Wednesday, January 8th. They issued a “buy” rating and a $700.00 price objective on the stock. Two analysts have rated the stock with a hold rating and fourteen have issued a buy rating to the stock. Based on data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and a consensus price target of $542.15.

Insider Transactions at Axon Enterprise

In related news, Director Caitlin Elizabeth Kalinowski sold 450 shares of the business’s stock in a transaction dated Thursday, January 2nd. The stock was sold at an average price of $604.07, for a total value of $271,831.50. Following the completion of the transaction, the director now owns 6,929 shares of the company’s stock, valued at $4,185,601.03. The trade was a 6.10 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, insider Jeffrey C. Kunins sold 2,304 shares of the company’s stock in a transaction on Tuesday, December 3rd. The stock was sold at an average price of $654.79, for a total value of $1,508,636.16. Following the sale, the insider now owns 128,542 shares of the company’s stock, valued at $84,168,016.18. The trade was a 1.76 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 8,711 shares of company stock valued at $5,631,561. 6.10% of the stock is currently owned by corporate insiders.

Axon Enterprise Stock Performance

NASDAQ:AXON opened at $593.42 on Thursday. The company has a current ratio of 2.96, a quick ratio of 2.63 and a debt-to-equity ratio of 0.32. The stock has a 50 day simple moving average of $624.50 and a 200 day simple moving average of $515.36. Axon Enterprise, Inc. has a 1-year low of $260.27 and a 1-year high of $715.99. The stock has a market cap of $45.25 billion, a P/E ratio of 153.34, a PEG ratio of 7.12 and a beta of 1.05.

About Axon Enterprise

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.